A PBM audit is not always a routine records request. What begins with a demand for invoices, proof of delivery, prescription records, copayment documentation, or purchase-to-dispense reconciliation can rapidly escalate into a far more serious threat to a pharmacy’s operations, revenue, and reputation.
When a PBM identifies alleged fraud, waste, abuse, billing irregularities, inventory discrepancies, non-dispensing, or documentation failures, it may take action well beyond issuing a recoupment demand or initiating a PBM network termination. Depending on the nature of the allegations and the applicable contracts or plan requirements, a PBM may report or refer concerns to CMS, state Medicaid agencies, Boards of Pharmacy, other payors, or outside enforcement and regulatory agencies.
PBM Findings Can Create the Road to a UPIC Audit
A report or referral does not establish wrongdoing, and an adverse PBM finding does not automatically result in a UPIC audit. But when reported concerns involve Medicare or Medicaid claims, the potential consequences can multiply.
A Unified Program Integrity Contractor (UPIC) performs Medicare and Medicaid program-integrity functions, including data analysis, audits, investigations, and referrals involving suspected fraud, waste, abuse, and improper payments. A PBM referral to CMS or another outside agency can place a pharmacy on the radar for broader scrutiny, particularly where the alleged issues involve claims patterns, inventory shortages, dispensing records, delivery documentation, copayment practices, or high-dollar medications.
The same documents a PBM requests during an audit may become central to a subsequent UPIC investigation, Medicaid review, or regulatory inquiry. What may initially appear to be a routine PBM audit can therefore develop into a larger program-integrity matter.
A PBM Recoupment May Be Only the Beginning
Pharmacies should not assume that repayment of claims that PBMs identified as discrepant will end all further inquiries. A PBM’s adverse findings can lead to payment disruption, PBM network termination, expanded document demands, additional payor audits, such as UPIC audits, Board of Pharmacy scrutiny, or referrals to enforcement authorities.
A pharmacy’s initial responses to PBM audit inquiries, and its subsequent appeal of adverse PBM audit findings, can materially shape the course of the matter. Incomplete records, unreconciled invoices, inaccurate dispensing reports, or unsupported explanations can deepen a PBM’s concerns and create avoidable exposure. Equally important, a pharmacy that does not submit a thorough, evidence-based appeal risks creating the appearance that it accepts allegations of improper claim submissions, inventory shortages, copayment waivers, non-dispensing, or other compliance violations asserted by the PBM.
A strategic PBM audit response and appeal should preserve the pharmacy’s rights, directly rebut unsupported findings, and present a complete, documented, and defensible account of the pharmacy’s claims, purchases, dispensing, and compliance practices. The goal is to correct the record early and eliminate any appearance of impropriety before a PBM audit escalates into a CMS referral, UPIC audit, or broader government investigation.
How HLA Can Help
Health Law Alliance represents pharmacies nationwide in PBM audits, PBM network terminations, CMS, and Medicaid audits, and UPIC audits and investigations. We help pharmacies evaluate allegations, preserve and organize critical records, reconcile claims and inventory, prepare strategic responses, pursue appeals, and defend against escalating regulatory scrutiny.
If your pharmacy has received adverse PBM audit findings, a PBM termination notice, a UPIC audit request, or adverse UPIC audit findings, contact us today for a free consultation.
